LLT1 and CD161 expression in human germinal centers promotes B cell activation and CXCR4 downregulation gan Llibre, A, López-Macías, C, Marafioti, T, Mehta, H, Partridge, A, Kanzig, C, Rivellese, F, Galson, J, Walker, L, Milne, P, Phillips, R, Kelly, D, Freeman, G, El Shikh, M, Klenerman, P, Willberg, C

Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biolo... gan Lliso, G, Humby, F, Lewis, M, Nerviani, A, Mauro, D, Rivellese, F, Kelly, S, Hands, R, Bene, F, Ramamoorthi, N, Hackney, JA, Cauli, A, Choy, EH, Filer, A, Taylor, PC, McInnes, I, Townsend, MJ, Pitzalis, C

Rituximab versus tocilizumab and B-cell status in TNF-alpha inadequate-responder rheumatoid arthritis patients: the R4-RA RCT gan Humby, F, Durez, P, Buch, MH, Lewis, MJ, Bombardieri, M, John, C, Rizvi, H, Warren, L, Peel, J, Fossati-Jimack, L, Hands, RE, Giorli, G, Rivellese, F, Cañete, JD, Taylor, PC, Sasieni, P, Fonseca, JE, Choy, E, Pitzalis, C

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial gan Rivellese, F, Surace, AEA, Goldmann, K, Sciacca, E, Çubuk, C, Giorli, G, John, CR, Nerviani, A, Fossati-Jimack, L, Thorborn, G, Ahmed, M, Prediletto, E, Church, SE, Hudson, BM, Warren, SE, McKeigue, PM, Humby, F, Bombardieri, M, Barnes, MR, Lewis, MJ, Pitzalis, C

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): A stratified, biopsy-driven, multi-centre, randomised, open label, controll... gan Humby, F, Durez, P, Buch, MH, Lewis, M, Rizvi, H, Rivellese, F, Nerviani, A, Giorli, G, Mahto, A, Montecucco, C, Lauwerys, B, Ng, N, Ho, P, Bombardieri, M, Romão, VC, Verschueren, P, Kelly, S, Sainaghi, PP, Gendi, N, Dasgupta, B, Cauli, A, Reynolds, P, Cañete, JD, Moots, R, Taylor, P, Edwards, CJ, Isaacs, J, Sasieni, P, Choy, E, Pitzalis, C

Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes gan Lewis, MJ, Barnes, MR, Blighe, K, Goldmann, K, Rana, S, Hackney, J, Ramamoorthi, N, John, CR, Watson, D, Kummerfeld, SK, Hands, R, Riahi, S, Rocher-Ros, V, Rivellese, F, Humby, F, Kelly, S, Bombardieri, M, Ng, N, Dicicco, M, Van Der Heijde, D, Landewe, R, Van Der Helm-Van Mil, A, Cauli, A, McInnes, IB, Buckley, CD, Choy, E, Taylor, PC, Townsend, MJ, Pitzalis, C

Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomise... gan Rivellese, F, Nerviani, A, Giorli, G, Warren, L, Jaworska, E, Bombardieri, M, Lewis, MJ, Humby, F, Pratt, AG, Filer, A, Gendi, N, Cauli, A, Choy, E, McInnes, I, Durez, P, Edwards, CJ, Buch, MH, Gremese, E, Taylor, PC, Ng, N, Cañete, JD, Raizada, S, McKay, ND, Jadon, D, Sainaghi, PP, Stratton, R, Ehrenstein, M, Ho, P, Pereira, JP, Dasgupta, B, Gorman, C, Galloway, J, Chinoy, H, van der Heijde, D, Sasieni, P, Barton, A, Pitzalis, C